CHIESI LIMITED
Company Information
- Company Number
- 02140985
- Registered Address
- 333 Styal Road, Manchester, M22 5LG
- Status
- Active
- Employee Count
- 337
- Turnover
- £367,995,000
- EBITDA
- £20,354,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 18 June 1987
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology
- Region
- North West
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 31 Jul 2025 | 11 | 88% | 7% | 5% | 28% |
| 01 Jul 2024 - 31 Dec 2024 | 04 Feb 2025 | 9 | 94% | 4% | 2% | 23% |
| 01 Jan 2024 - 30 Jun 2024 | 29 Jul 2024 | 10 | 93% | 6% | 1% | 27% |
| 01 Jul 2023 - 31 Dec 2023 | 18 Jan 2024 | 12 | 93% | 5% | 2% | 48% |
| 01 Jul 2022 - 31 Dec 2022 | 06 Feb 2023 | 18 | 92% | 5% | 3% | 37% |
| 01 Jan 2022 - 30 Jun 2022 | 15 Aug 2022 | 17 | 93% | 5% | 2% | 38% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 15 | 91% | 6% | 3% | 39% |
| 01 Jan 2020 - 30 Jun 2020 | 29 Jul 2020 | 15 | 91% | 7% | 2% | 56% |
| 01 Jul 2019 - 31 Dec 2019 | 03 Feb 2020 | 15 | 94% | 4% | 2% | 70% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 15 | 92% | 6% | 2% | 68% |
| 01 Jan 2018 - 30 Jun 2018 | 25 Jul 2018 | 15 | 89% | 9% | 2% | 73% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Intercompany invoices are payable 60 days after end of month of receipt. Non intercompany invoices are payable within 30 days of receipt of invoice.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
Disputes are extremely rare. However, should there be a dispute or query then suppliers are advised to make contact and discuss with their usual point of reference at Chiesi Ltd. If it is not possible to find a resolution then suppliers are advised to request an escalation to Accounts Payable Department, and then to Chiesi Ltd Finance Management if necessary.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
CHIESI LIMITED is a pharmaceutical company based in the United Kingdom. The company is committed to providing innovative and sustainable healthcare solutions to improve the lives of patients.
One of the key activities of CHIESI LIMITED is the development, manufacturing, and distribution of a wide range of pharmaceutical products. These include treatments for respiratory diseases, neonatology, rare diseases, and special care therapies.
In line with their commitment to sustainability, CHIESI LIMITED has implemented a number of initiatives to reduce their environmental impact. This includes reducing their carbon footprint, promoting sustainable packaging, and investing in renewable energy sources. They also have a dedicated sustainability program that focuses on improving the well-being of patients, employees, and the communities they operate in.
Some of the key people at CHIESI LIMITED include the Managing Director, Dr. Victor Castiglione, and the Head of Sustainability, Dr. Elisa Salvi. The company also has a team of skilled researchers, scientists, and healthcare professionals who work towards developing and delivering high-quality healthcare solutions.
For more information on CHIESI LIMITED and their products and services, you can visit their website at www.chiesi.uk.com. Their registered office address is 333 Styal Road, Manchester, M22 5LG, United Kingdom. Overall, CHIESI LIMITED is a leading pharmaceutical company that prioritizes sustainability and strives to improve the lives of patients through their innovative products and initiatives.
